A prospective cross sectional study on 150 consecutive patients screening for esophageal varices.
Patient groups groups:
Group (1): 100 patients with esophageal varices
Group (2): 50 chronic liver disease patients with no esophageal varices as a control group.
All patients will be subjected to:
1. \- Detailed history-taking
2. \- Full clinical examination
3. \- Laboratory investigations:
* Complete blood picture (CBC)
* Erythrocyte sedimentation rate (ESR)
* Renal function tests
* Liver function tests
* Prothrombin time and activity
* Viral markers (HCV Ab - HBV Ag)
* Blood ammonia level.
4. \- Pelviabdominal US: Ultrasound examination of the liver, portal venous system, spleen, kidney and other abdominal organs.
5. \- Upper GITendoscopy:
* Varices will be classified according to the Japanese classification 1996,
* The Baveno 11 score will be used to differentiate between mild and severe portal hypertensive gastropathy.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients with chronic liver disease
You may not be if
Patient in hepatic encephalopathy or coma.
Patient in active bleeding or with history of bleeding within the two weeks prior to entry in the study .
Patients with heart failure.
Patients with renal failure.
Patient with hepatocellular carcinoma and portal vein thrombosis.